Literature DB >> 7496971

Characterization of substance P binding to human monocytes/macrophages.

D R Lucey1, J M Novak, V R Polonis, Y Liu, S Gartner.   

Abstract

Substance P (SP), a member of the tachykinin family of neuropeptides, can immunomodulate human T cells and monocytes. SP has been shown to stimulate human monocytes to produce inflammatory cytokines and superoxide ions, and it enhances tumoricidal activity in vitro. A specific SP receptor, however, has not been identified on human monocytes/macrophages. In this study, we report that 125I-SP binds to human monocytes/macrophages with high affinity and specificity (Kd = 2.7 x 10(-8) to 5.5 x 10(-8) M). Our measurements of binding affinity to this single class of receptors were possible only when experiments were performed in the presence of excess serine proteinase inhibitor (serpin) enzyme complex receptor ligand. We determined that 125I-SP bound to a specific receptor on human monocytes/macrophages and that this binding was detectable as early as 6 h and was maintained throughout 6 to 8 weeks in culture. Modulation of the diverse immunological and inflammatory effects of SP on human monocytes may be mediated through this specific SP receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496971      PMCID: PMC368257          DOI: 10.1128/cdli.1.3.330-335.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  38 in total

1.  Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation.

Authors:  T Hirata; P B Bitterman; J F Mornex; R G Crystal
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

2.  Substance P: binding properties and studies on cellular responses in guinea pig macrophages.

Authors:  H P Hartung; K Wolters; K V Toyka
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

Review 3.  Chemoattractant receptors on phagocytic cells.

Authors:  R Snyderman; M C Pike
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 4.  Substance P.

Authors:  B Pernow
Journal:  Pharmacol Rev       Date:  1983-06       Impact factor: 25.468

Review 5.  Neuropeptides and inflammation: the role of substance P.

Authors:  D G Payan
Journal:  Annu Rev Med       Date:  1989       Impact factor: 13.739

6.  Platelet-derived growth factor promotes human peripheral monocyte activation.

Authors:  D Y Tzeng; T F Deuel; J S Huang; R L Baehner
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

7.  Substance P receptor-mediated chemotaxis of human monocytes.

Authors:  M R Ruff; S M Wahl; C B Pert
Journal:  Peptides       Date:  1985       Impact factor: 3.750

8.  Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis.

Authors:  M Ruff; E Schiffmann; V Terranova; C B Pert
Journal:  Clin Immunol Immunopathol       Date:  1985-12

9.  Substance P, a neuropeptide, inhibits measles virus replication in cell culture.

Authors:  C Schroeder
Journal:  Acta Virol       Date:  1986-09       Impact factor: 1.162

10.  Substance P and immunoregulation.

Authors:  J P McGillis; M L Organist; D G Payan
Journal:  Fed Proc       Date:  1987-01
View more
  10 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

3.  Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA.

Authors:  Jian-Ping Lai; Steven D Douglas; Yan-Jian Wang; Wen-Zhe Ho
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

4.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.

Authors:  Mohammad M Khan; Steven D Douglas; Tami D Benton
Journal:  J Neuroimmunol       Date:  2011-11-23       Impact factor: 3.478

6.  Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.

Authors:  T Goode; J O'Connell; W Z Ho; G C O'Sullivan; J K Collins; S D Douglas; F Shanahan
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.

Authors:  J-P Lai; W Z Ho; L E Kilpatrick; X Wang; F Tuluc; H M Korchak; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

8.  Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.

Authors:  Jian-Ping Lai; Avital Cnaan; Huaqing Zhao; Steven D Douglas
Journal:  J Neurosci Methods       Date:  2007-10-17       Impact factor: 2.390

9.  Substance P augments tumor necrosis factor release in human monocyte-derived macrophages.

Authors:  H R Lee; W Z Ho; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

10.  Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).

Authors:  Irene Chernova; Jian-Ping Lai; Haiying Li; Lynnae Schwartz; Florin Tuluc; Helen M Korchak; Steven D Douglas; Laurie E Kilpatrick
Journal:  J Leukoc Biol       Date:  2008-10-03       Impact factor: 4.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.